{"product_id":"vdrlrpr-flocculation-titer-csf","title":"VDRL(RPR), Flocculation,Titer,CSF","description":"\u003cp\u003eHere’s \u003cstrong\u003estructured, professional content\u003c\/strong\u003e for:\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003e\u003cstrong\u003eVDRL, Titre (Quantitative) – Serum | Test Code: V0003c\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cstrong\u003eTest Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eThe \u003cstrong\u003eVDRL (Venereal Disease Research Laboratory) Titre test\u003c\/strong\u003e is a \u003cstrong\u003equantitative blood test\u003c\/strong\u003e used to detect and measure antibodies produced in response to \u003cem\u003eTreponema pallidum\u003c\/em\u003e, the bacterium responsible for \u003cstrong\u003eSyphilis\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eUnlike the qualitative VDRL test, this test provides a \u003cstrong\u003etitre value\u003c\/strong\u003e, indicating the \u003cstrong\u003econcentration of antibodies\u003c\/strong\u003e, which is crucial for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAssessing disease activity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMonitoring treatment effectiveness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eDetecting reinfection or relapse\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eSpecimen Required\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSample Type:\u003c\/strong\u003e Serum\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVolume:\u003c\/strong\u003e 2–3 mL blood\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eContainer:\u003c\/strong\u003e Plain (Red\/Yellow top tube)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eMethodology\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFlocculation Test (Quantitative)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003ePreparation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eFasting:\u003c\/strong\u003e Not required\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSpecial Instructions:\u003c\/strong\u003e Inform clinician about ongoing treatment or past infection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eClinical Significance\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003e1. Diagnosis Support\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eHelps confirm suspected \u003cstrong\u003esyphilis infection\u003c\/strong\u003e along with treponemal tests\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003e2. Disease Monitoring\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eTitre levels decrease with successful treatment\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRising titres may indicate:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eTreatment failure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eReinfection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003e3. Screening Utility\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eCommonly used in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAntenatal screening\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eBlood donor screening\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eResult Interpretation\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003cstrong\u003eTitre Value\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth\u003e\u003cstrong\u003eInterpretation\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon-reactive\u003c\/td\u003e\n\u003ctd\u003eNo detectable antibodies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLow titre\u003c\/td\u003e\n\u003ctd\u003eEarly \/ treated infection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh titre\u003c\/td\u003e\n\u003ctd\u003eActive infection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFourfold change\u003c\/td\u003e\n\u003ctd\u003eSignificant change in disease status\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cblockquote\u003e\n\u003cp\u003e⚠️ \u003cstrong\u003eNote:\u003c\/strong\u003e Results should always be correlated with confirmatory treponemal tests (e.g., TPHA\/FTA-ABS).\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eLimitations\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eMay produce \u003cstrong\u003efalse positives\u003c\/strong\u003e in conditions such as:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAutoimmune diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePregnancy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eCertain viral infections\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eNot specific for \u003cem\u003eTreponema pallidum\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eTurnaround Time (TAT)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSame day \/ 24 hours\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eUse Case Summary\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e✔ Disease activity assessment\u003cbr\u003e✔ Treatment monitoring\u003cbr\u003e✔ Follow-up testing\u003cbr\u003e✔ Screening in clinical programs\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eSuggested Add-ons\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eTPHA (Treponema Pallidum Hemagglutination)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eFTA-ABS (Fluorescent Treponemal Antibody Test)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cstrong\u003eSEO Hashtags\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e#VDRL #SyphilisTest #TitreTest #STDTesting #BloodTest #DiagnosticLab #BiocareLabs #HealthScreening #InfectionTesting #LabTests\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Lifecell Diagnostics","offers":[{"title":"Default Title","offer_id":44007369801863,"sku":null,"price":105.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0691\/4241\/3447\/files\/39d88ade-0946-46d0-b897-911e04dfcec6.png?v=1777970608","url":"https:\/\/ourdermastore.com\/products\/vdrlrpr-flocculation-titer-csf","provider":"Ourdermastore ","version":"1.0","type":"link"}